Exciton Signs Exclusive Distribution Agreement for Canada

EDMONTON, Nov. 28, 2011 /CNW/ - Exciton Technologies Inc. today announced the signing of an exclusive agreement with Medical Mart to distribute the Company's exsalt™ SD7 Wound Dressing throughout Canada.

"We are pleased to be offering a Canadian made product through a successful Canadian distribution company", says Rod Precht, President and Founder of Exciton Technologies Inc. "Medical Mart is the ideal partner to distribute our flagship product incorporating Exciton's platform silver technology".

The arrangement allows Exciton to expand the availability of its antimicrobial silver wound dressing throughout the entire Canadian healthcare system, from home health to primary care to emergency units. Medical Mart has over forty sales representatives, four warehouses and is recognized as the industry leader in medical product distribution.

"Partnering with Exciton made sense as the market conditions are ideal to introduce a product with superior attributes over other silver technologies," says Robert J West, Executive Vice President, of Medical Mart, "Medical Mart has been providing innovative health care solutions to Canadians since my father started this company over 30 years ago. The health care industry has changed significantly since we opened our doors, and Medical Mart in turn, has grown to accommodate the diverse requirements of our valued customers."

About exsalt™ SD7 Wound Dressing
The exsalt™ SD7 Wound Dressing is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second degree burns, grafts and donor sites, and other acute or chronic wounds.  The exsalt™ SD7 Wound Dressing maintains its broad spectrum antimicrobial activity for up to seven days. With a long history of safety, silver continues to be the most promising antimicrobial treatment in the market.

About Exciton Technologies Inc.
Exciton Technologies Inc. is a privately held Alberta advanced materials research and development company focused on the creation of technologies for preventing and controlling infection. Currently our valuable portfolio of patentable platform technologies is based on the antimicrobial properties of silver. The Company's technologies offer next-generation and less expensive products, enabling the company to participate in many industries, including the wound care and disinfectant markets.

About Medical Mart
A privately-owned Canadian sales, wholesale and distribution company, Medical Mart provides full service solutions to the health care industry. Since opening its doors in 1978, Medical Mart has specialized in meeting the needs of the health care provider, through reliable service and the promotion of quality products.

Forward-looking Statements
This press release may contain forward-looking statements. Forward looking statements, including the Company's belief as to the potential of its products, the Company's expectations regarding the issuance of additional patents and the Company's ability to protect its intellectual property, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the ability to economically manufacture its products, the potential of its products, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize its products, the ability of the Company to defend its patents from infringement by third parties, and the risk that the Company's patents may be subsequently shown to be invalid or infringe the patents of others. Investors should consult the Company's quarterly and annual filings with the Canadian commissions for additional information on risks and uncertainties relating to the forward- looking statements. Investors are cautioned against placing undue reliance on forward-looking statements.

For further information: